Biomedical subjects

Smita Dube

Publications and source records attributed to Smita Dube.

4 recordsLinked to original sources

PubMed2006

Characterisation of laboratory-generated vancomycin intermediate resistant Staphylococcus aureus strains.

Vancomycin has been the drug of choice for 30 years for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). Emergence of decreased vancomycin susceptibility in MRSA strains presents a significant clinical problem with few therapeutic options. This study was performed to generate and characterise S. aureus strains with reduced susceptibility to vancomycin. Eighteen S. aureus strains were subjected to serial passaging on vancomycin to generate vancomycin intermediate resistant S. aureus (VISA) strains. Minimum inhibitory concentration (MIC) determination was performed for the parent and the passaged cultures with 13 different antibiotics. The strains were tested by the following five methods: simplified population analysis; CDC method; modified vancomycin agar screen; population analysis profile (PAP); and modified population analysis (PAP-area under the curve (AUC) ratio). Phenotypic changes such as doubling time, synergy with beta-lactam antibiotics and effect on norA efflux pumps were also studied for these strains. The result indicated that 8 VISA mutants (vancomycin MICs, 8-16 microg/mL) were generated in vitro from the 18 S. aureus strains. The CDC and modified agar methods proved to be the most sensitive and specific methods for detection of VISA strains. The PAP for all the VISA strains ranged from 12 microg/mL to > 16 microg/mL, with a PAP-AUC ratio of > 1.3. All mutants showed increased doubling time compared with their parent isolate. Synergism of the vancomycin and beta-lactam combinations was observed for all methicillin-resistant mutants. Upon acquisition of vancomycin resistance, a few mutants showed decreased oxacillin resistance. Two VISA strains were chosen for molecular characterisation of the mecA gene and one mutant showed genotypic changes with deletion of mecA. Loss of norA efflux pumps leading to fluoroquinolone sensitivity was also observed in four mutants.

Laboratories↗

PubMed2005

Bacillus arsenicus sp. nov., an arsenic-resistant bacterium isolated from a siderite concretion in West Bengal, India.

Strain Con a/3(T) is a Gram-positive, motile, endospore-forming, rod-shaped and arsenic-resistant bacterium, which was isolated from a concretion of arsenic ore obtained from a bore-hole. The bacterium grew in the presence of 20 mM arsenate and 0.5 mM arsenite. Diaminopimelic acid was present in the cell wall peptidoglycan, MK-7 was the major menaquinone, and iso-C(15 : 0), anteiso-C(15 : 0), iso-C(16 : 0) and C(16 : 1)(delta7cis) were the major fatty acids. Based on its phenotypic, chemotaxonomic and phylogenetic characteristics, strain Con a/3(T) was identified as a member of the genus Bacillus. It exhibited maximum similarity (97 %) at the 16S rRNA gene level with Bacillus barbaricus (DSM 14730(T)); however, the DNA-DNA relatedness value with B. barbaricus was 60 %. Strain Con a/3(T) also exhibited a number of phenotypic differences from B. barbaricus (DSM 14730(T)). Strain Con a/3(T) was therefore identified as representing a novel species of the genus Bacillus, for which the name Bacillus arsenicus sp. nov. is proposed. The type strain is Con a/3(T) (= MTCC 4380(T) = DSM 15822(T) = JCM 12167(T)).

Anti-Bacterial Agents↗

PubMed2004

Pseudonocardia antarctica sp. nov. an Actinomycetes from McMurdo Dry Valleys, Antarctica.

Strain DVS 5a1 was isolated from a moraine sample from the McMurdo Dry Valleys region of Antarctica. The strain is aerobic, Gram-positive, with white aerial mycelia and brown substrate mycelia, sporulating, has meso-diaminopimelic acid, arabinose and galactose in the cell wall, MK-8 (H4) as the major menaquinone and a mol% G+C content of DNA of 71% thus confirming to the description of the genus Pseudonocardia. Phylogenetic analysis based on the 16S rRNA gene sequence analysis further confirms that DVS 5al which forms a robust clade with P. alni, P. compacta, P. autotrophica and P. kongjuensis is closely related to the genus Pseudonocardia and exhibits maximum similarity of 99.7% with Pseudonocardia alni. However, at whole genome level as determined by DNA-DNA hybridisation DVS 5al exhibits a similarity of only 50% with Pseudonocardia alni. Further, DVS 5al differs from Pseudonocardia alni in that it does not produce acid from D-arabinose, meso-erythritol, melizitose, sorbitol, sucrose, D-trehalose; but produces acid from D-mannitol, D-galactose, D-maltose, D-mannose, inulin, D-ribose and D-xylose. Further, compared to Pseudonocardia alni, it has two additional fatty acids namely Me-C(18:0) and Me-C(19:0) and also possesses one additional unidentified lipid. It also shows distinct differences with P. compacta, P. autotrophica and P. kongjuensis and the other species of Pseudonocardia. It is proposed to assign DVS 5a1 the status of a new species for which the name Pseudonocardia antarctica sp. nov. is suggested.

Antarctic Regions↗

PubMed2003

Psychrophilic Planococcus maitriensis sp.nov. from Antarctica.

An orange pigmented bacterium, S1, was isolated from a cyanobacterial mat sample collected in the vicinity of Schirmacher Oasis, Maitri, the Indian station, in Antarctica. The bacterium is Gram-positive and possesses all the characteristics of the genus Planococcus. It is non-sporulating, motile and has A4alpha type peptidoglycan, MK-7 and MK-8 as the major menaquinones and anteiso-C(15:0) as the major fatty acid. Based on the phylogenetic characteristics, the bacterium S1 is identified as a close relative of Planococcus citreus with which it shares 98.12% similarity at the 16S rRNA gene level but exhibits a low similarity of 52% at the whole genome level. Apart from the above major differences, S1 also exhibits phenotypic differences with Planococcus citreus and other members of the genus Planococcus. Based on these differences, the bacterium S1 is identified as a new species of the genus Planococcus for which the name Planococcus maitriensis is proposed. The type strain of Planococcus maitriensis is S1(T) (= MTCC 4827; DSM 15305).

Antarctic Regions↗